semaglutide ckd trial Kidney and Survival Benefits of in Diabetes With Chronic Kidney Disease: FLOW Cardiovascular Subgroup Analyses Semaglutide in patients with overweight

Best Med #2: GLP-1 Receptor Agonists Next up: glucagon-like peptide 1 receptor agonists, known colloquially (and identified here) as GLPs

In major clinical trials, such as the landmark STEP 1 trial published in the New England Journal of Medicine , a once-weekly injection of semaglutide 2.4 mg resulted in an average body weight reduction of roughly 14.9% over 68 weeks

Think of every prepped meal as a three-part plate designed around a simple priority order: protein first, fiber second, complex carbohydrates third

Ozempic focuses on two things: better blood sugar control and weight loss

Participants in the GLP-1RA group reported lower craving of alcohol overall, although craving did rise over the course of the drinking session, as in the control group

This tropical fruit flavoured liquid vitamin C can be taken straight from the spoon or mixed into water